Icosapent ethyl cost effective in REDUCE-IT analysis
Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
The SGLT2 inhibitor had similar efficacy in the elderly and across the spectrum of baseline symptom status.
Colchicine cut post-MI CVD events
Colchicine fulfilled the promise first seem in CANTOS that anti-inflammatory treatment can reduce cardiovascular disease events.
Cardiac arrests peak with pollution in Japan
The incidence of out-of-hospital cardiac arrests in Japan increased on days when counts of particulate matter spiked from the day before.
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeTweets
Top stories from the American Heart Association scientific sessions
Vascepa gains event-reduction nod; diabetes ups ischemic risks
Post-STEMI events less likely in women; bariatric surgery may lower stroke risk
Card Talk: TAVR and glass ceilings
ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special
Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF
Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk
How risk factors in childhood translate to CV outcomes in adulthood
Driving while defibrillating; hypertension holds greater risk in black patients
AFib hits Native Americans hard; TAVR shown durable, safe after 5 years
Practice changing prevention data from ESC 2019 Part II
Statins tied to skin, soft tissue infections; new Card Talk episode
Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis
Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk
Cardiology dead last as women’s IM subspecialty choice
An antiplatelet surprise; Europeans go low in cholesterol guidelines
SGLT-2 inhibitors and more practice changing data from ESC 2019
Overweight BMI surpasses 'normal' and introducing the 'Card Talk' segment
Dapagliflozin transforms into heart failure drug
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive